As Congress debates the future of Reconciliation 3.0, Republicans face mounting pressure to balance fiscal discipline with advancing their legislative agenda. In a new Washington Examiner op-ed, Market Institute President Charles Sauer argues lawmakers don’t have to choose between the two. Instead, Sauer points to long-overdue reforms within Medicare and Read more…
America’s patent system helped transform the United States into the world’s leading innovation economy by ensuring that anyone—not just the politically connected—could protect and profit from their ideas. But today, that competitive advantage is increasingly threatened by a regulatory system that leaves businesses waiting for answers instead of bringing new Read more…
A new Supreme Court ruling marks another significant step toward reining in the administrative state and restoring constitutional accountability. Writing in RealClearMarkets, Market Institute President Charles Sauer argues that while Trump v. Slaughter strengthens presidential oversight of federal agencies, Congress must continue the work by reclaiming its constitutional lawmaking authority. Read more…
The Market Institute has joined the Center for a Free Economy and more than three dozen national organizations in urging Congress to pass the USTRx Act (H.R. 4780), legislation that would help end the unfair practice of foreign governments shifting the cost of pharmaceutical innovation onto American patients. In a Read more…
The healthcare system is often described as broken, but as Charles Sauer explained during a recent event hosted by the Mises Institute, the solutions already exist. The challenge is not creating better models of care—it’s removing the government policies that prevent them from flourishing. Recorded on June 27 in Windham, Read more…
A bipartisan effort in Congress seeks to reinforce First Amendment protections by preventing federal officials from pressuring private companies to censor lawful speech. In a new RealClearMarkets column, Market Institute Senior Fellow Norm Singleton examines the Justice Against Weaponized Bureaucratic Overreach to Networked Expression (JAWBONE) Act and explains why it Read more…
A new opinion piece by Market Institute President Charles Sauer in RealClearMarkets argues that policymakers should resist efforts to ban personalized pricing, warning that government intervention would undermine consumer choice and market efficiency. As retailers like Kroger and Walmart adopt digital shelf labels, critics have raised concerns over so-called “surveillance Read more…
A newly published paper in The Milbank Quarterly adds to the growing body of evidence that the federal 340B Drug Pricing Program has strayed far from its original purpose, strengthening the case for meaningful congressional reform. In a recent RealClearMarkets commentary, Market Institute Senior Fellow Norm Singleton highlights Stretching Scarce Read more…
A new RealClearHealth op-ed by Dr. Craig Wax argues that if Congress is serious about reducing healthcare costs and increasing competition, lawmakers must reform one of the federal government’s biggest distortions: Medicare’s unequal payment system. Dr. Wax explains how current Medicare policy allows hospital systems to charge significantly more than Read more…
The American Innovation and Choice Online Act (AICOA) is back before Congress, and in a new RealClearMarkets op-ed, Market Institute Senior Fellow Norm Singleton argues lawmakers should finally let the legislation die. Comparing the bill to Dr. Frankenstein’s infamous creation, Singleton writes that Senators Amy Klobuchar and Charles Grassley continue Read more…